The effects of the frequency of the initial treatment with intravitreal bevacizumab on macular volume and visual acuity.
Phase of Trial: Phase IV
Latest Information Update: 09 Mar 2016
At a glance
- Drugs Bevacizumab (Primary)
- Indications Age-related macular degeneration; Choroidal neovascularisation
- Focus Therapeutic Use
- 09 Mar 2016 New trial record